Abiopharma

🔍 HOCHSCHILD ROGER C (Director)

Company: PRINCIPAL FINANCIAL GROUP INC (PFG)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 294 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 41,477.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 219 shares of Phantom Stock Units (Derivative)
  Date: 2026-06-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 29,674.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: Grant of restricted stock units.
• F2: The units convert to common stock on a one-for-one basis.
• F3: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and may be transferred at any time into another investment alternative under the Plan. Interests under the Plan will be settled upon the reporting person's retirement.